Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 138th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
LYRA	LYRA THERAPEUTICS INC	$10.33M	-412.00%	-61.20%	-93.74%	-75.60%	31.41	2.78	100.00%	-5,043.60%	-5,041.17%
IBIO	IBIO INC	$17.59M	-126.90%	-83.10%	-106.36%	-250.50%	0.56	1.59	100.00%	-4,594.30%	-4,541.25%
ONCO	ONCONETIX INC	$4.79M	-350.60%	-143.40%	-685.85%	819.20%	2.16	0.07	66.40%	-3,458.20%	-3,321.76%
SLDB	SOLID BIOSCIENCES INC	$427.50M	-71.90%	-58.50%	-55.23%	-113.40%	0.19	9.34	N/A	N/A	N/A
ELVN	ENLIVEN THERAPEUTICS INC	$1.10B	-29.20%	-27.90%	-20.51%	-43.10%	0.03	32.58	N/A	N/A	N/A
CLSD	CLEARSIDE BIOMEDICAL INC	$20.67M	N/A	-124.10%	-219.76%	-47.60%	-1.32	3.87	70.50%	-2,061.90%	-2,008.71%
VOR	VOR BIOPHARMA INC	$202.69M	N/A	-1,160.80%	-1,135.37%	-3,792.40%	-1.14	3.49	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$271.07M	-287.20%	-138.80%	-130.09%	-1,400.20%	0.66	2.45	100.00%	-3,220.50%	-3,217.23%
JAGX	JAGUAR HEALTH INC	$4.28M	-530.10%	-76.80%	-215.16%	-107.80%	5.18	0.96	81.90%	-344.20%	-347.06%
HYPD	HYPERION DEFI INC	$65.83M	-878.40%	-182.10%	-83.30%	-315.90%	0.49	0.91	-7,177.30%	-90,270.20%	-85,006.99%
OGEN	ORAGENICS INC	$909.11k	-954.70%	-311.80%	-7,344.29%	3,865.20%	27.10	1.04	N/A	N/A	N/A
GLMD	GALMED PHARMACEUTICALS LTD	$7.74M	-48.30%	-43.00%	-45.36%	-78.30%	0.12	8.71	N/A	N/A	N/A
TERN	TERNS PHARMACEUTICALS INC	$623.95M	-27.40%	-26.20%	-29.75%	-57.20%	0.05	24.70	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$124.83M	-46.40%	-37.40%	-48.71%	396.20%	0.15	8.40	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$1.19B	-29.30%	-27.90%	-30.38%	-40.00%	0.06	15.99	100.00%	-1,544.00%	-1,544.02%
EYPT	EYEPOINT PHARMACEUTICALS INC	$922.77M	-54.30%	-41.80%	-45.71%	-62.60%	0.22	7.85	93.30%	-261.90%	-261.73%
ACLX	ARCELLX INC	$4.14B	-35.30%	-22.70%	-36.07%	-35.20%	0.56	4.93	100.00%	-211.50%	-251.56%
JBIO	JADE BIOSCIENCES INC	$230.67M	-52.00%	-47.60%	-27.81%	-211.00%	0.11	10.31	N/A	N/A	N/A
ATON	ALPHATON CAPITAL CORP	$9.38M	-347.70%	-135.50%	-602.49%	2,165.50%	-24.81	2.02	N/A	N/A	N/A
VIR	VIR BIOTECHNOLOGY INC	$665.41M	-50.20%	-40.80%	-50.57%	-55.80%	0.26	7.01	96.10%	-2,895.90%	-2,894.48%
AVIR	ATEA PHARMACEUTICALS INC	$260.16M	-31.30%	-29.30%	-33.14%	-42.80%	0.07	19.94	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$333.72M	-27.10%	-26.10%	-29.65%	-29.50%	0.05	25.13	N/A	N/A	N/A
JUNS	JUPITER NEUROSCIENCES INC	$55.73M	-835.30%	-155.10%	-429.83%	975.20%	1.96	1.07	N/A	N/A	N/A
TVGN	TEVOGEN BIO HOLDINGS INC	$165.63M	N/A	-782.00%	822.83%	1,528.10%	-1.45	0.26	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$46.14M	N/A	-134.40%	460.17%	-40.30%	-1.24	0.76	-144.60%	-5,869.80%	-4,022.24%
CLRB	CELLECTAR BIOSCIENCES INC	$16.44M	-265.50%	-125.70%	-370.52%	391.30%	1.02	2.15	N/A	N/A	N/A
NKTR	NEKTAR THERAPEUTICS	$608.07M	-262.10%	-43.90%	-57.01%	-34.20%	17.65	3.24	74.60%	-152.50%	-121.08%
TAOX	TAO SYNERGIES INC	$20.75M	-283.90%	-154.10%	-150.95%	-1,705.40%	0.11	20.51	100.00%	-735,871.70%	-717,300.61%
VERU	VERU INC	$51.86M	-137.20%	-81.60%	-155.40%	-430.50%	0.78	2.42	40.40%	-491.40%	-482.04%
DNLI	DENALI THERAPEUTICS INC	$1.92B	-40.80%	-36.40%	-44.55%	-41.50%	0.14	10.27	N/A	N/A	N/A
NUVL	NUVALENT INC	$5.72B	-33.20%	-30.70%	-35.51%	-39.70%	0.11	13.57	N/A	N/A	N/A
AURA	AURA BIOSCIENCES INC	$370.86M	-64.40%	-54.20%	-53.41%	-72.20%	0.17	12.39	N/A	N/A	N/A
SMMT	SUMMIT THERAPEUTICS INC	$14.07B	-208.60%	-181.30%	-279.62%	-375.80%	0.25	5.13	N/A	N/A	N/A
ORKA	ORUKA THERAPEUTICS INC	$571.50M	-27.90%	-25.90%	-28.81%	-45.50%	0.04	27.42	N/A	N/A	N/A
SNGX	SOLIGENIX INC	$11.79M	-274.80%	-129.20%	-518.78%	439.40%	2.15	1.47	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.08B	-26.60%	-24.60%	-22.12%	-32.80%	0.08	32.11	N/A	N/A	N/A
MRNA	MODERNA INC	$9.29B	-27.50%	-21.20%	-28.21%	-26.80%	0.28	3.93	52.50%	-94.30%	-95.68%
ALXO	ALX ONCOLOGY HOLDINGS INC	$56.23M	-115.70%	-84.80%	-150.24%	-107.50%	0.48	4.52	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$510.26M	-53.10%	-46.10%	-60.32%	-65.30%	0.25	7.66	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$2.18B	-70.00%	-48.00%	-50.05%	-212.70%	0.48	10.10	89.40%	-382.50%	-360.75%
MRUS	MERUS NV	$5.15B	-55.30%	-46.20%	-45.90%	-98.30%	0.16	8.39	100.00%	-555.60%	-587.80%
INKT	MINK THERAPEUTICS INC	$64.54M	N/A	-227.20%	105.57%	291.80%	-1.10	0.15	N/A	N/A	N/A
CGEN	COMPUGEN LTD	$129.08M	-34.80%	-16.80%	-17.27%	-68.00%	1.12	4.74	62.30%	-87.40%	-67.02%
KLTO	KLOTHO NEUROSCIENCES INC	$35.97M	-325.90%	-242.20%	-80.67%	1,735.50%	0.02	135.74	N/A	N/A	N/A
NNVC	NANOVIRICIDES INC	$23.30M	-95.40%	-84.30%	-110.12%	-160.10%	0.14	2.28	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$290.53M	-94.70%	-73.40%	-78.94%	-163.10%	0.27	4.43	N/A	N/A	N/A
SILO	SILO PHARMA INC	$7.53M	-94.40%	-68.60%	-87.28%	-305.10%	0.35	6.07	91.90%	-6,789.20%	-6,782.19%
MAIA	MAIA BIOTECHNOLOGY INC	$56.42M	-459.70%	-152.90%	-269.45%	445.20%	1.85	2.19	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$1.73B	-120.20%	-89.40%	-131.13%	-158.00%	0.77	4.19	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$192.47M	-17.80%	-14.60%	-17.93%	-17.40%	0.18	18.64	100.00%	-92.30%	-96.77%
QNCX	QUINCE THERAPEUTICS INC	$85.94M	-186.10%	-42.10%	-44.55%	-92.30%	8.99	5.00	N/A	N/A	N/A
NVCT	NUVECTIS PHARMA INC	$157.58M	-150.80%	-94.80%	-130.79%	260.90%	0.60	2.67	N/A	N/A	N/A
NGNE	NEUROGENE INC	$249.04M	-33.30%	-30.30%	-29.94%	-44.10%	0.09	18.07	N/A	N/A	N/A
XENE	XENON PHARMACEUTICALS INC	$2.78B	-38.50%	-36.50%	-44.07%	-45.70%	0.06	15.14	100.00%	-3,709.70%	-3,767.93%
CRNX	CRINETICS PHARMACEUTICALS INC	$3.16B	-30.90%	-28.10%	-25.17%	-35.80%	0.09	22.53	100.00%	-43,191.10%	-43,191.05%
VNDA	VANDA PHARMACEUTICALS INC	$258.81M	-12.90%	-10.50%	-16.89%	-25.70%	0.29	3.25	94.40%	-32.90%	-41.77%
TARA	PROTARA THERAPEUTICS INC	$121.92M	-36.90%	-33.80%	-34.56%	-83.20%	0.09	12.82	N/A	N/A	N/A
CELU	CELULARITY INC	$58.45M	-6,372.60%	-57.70%	-128.73%	-65.20%	-5.72	0.25	55.10%	-165.40%	-147.39%
ACRV	ACRIVON THERAPEUTICS INC	$47.50M	-50.80%	-46.10%	-59.22%	-64.10%	0.11	10.31	N/A	N/A	N/A
CBIO	CRESCENT BIOPHARMA INC	$169.77M	-103.40%	-86.60%	-28.51%	773.10%	0.13	9.21	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$213.81M	-61.20%	-28.10%	-36.59%	3,848.40%	1.05	3.76	100.00%	-231.50%	-222.96%
CDT	CONDUIT PHARMACEUTICALS INC	$2.06M	N/A	-349.40%	-507.47%	33,919.60%	1.26	1.45	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$57.40M	-42.60%	-37.80%	-47.37%	-46.40%	0.14	13.84	N/A	N/A	N/A
HOWL	WEREWOLF THERAPEUTICS INC	$65.39M	-111.90%	-62.70%	-87.95%	-174.60%	1.23	5.30	N/A	N/A	N/A
BCAB	BIOATLA INC	$33.77M	-357.90%	-111.70%	-277.67%	601.20%	69.00	2.35	100.00%	-562.50%	-562.51%
SRRK	SCHOLAR ROCK HOLDING CORP	$3.24B	-127.10%	-90.10%	-108.59%	-135.40%	0.46	6.33	N/A	N/A	N/A
PRTA	PROTHENA CORP PUBLIC LTD CO	$439.25M	-67.90%	-59.50%	-78.99%	-1,191.10%	0.23	5.69	100.00%	-2,929.30%	-2,530.46%
PMVP	PMV PHARMACEUTICALS INC	$59.23M	-32.50%	-29.60%	-49.22%	-51.80%	0.07	16.75	N/A	N/A	N/A
ACET	ADICET BIO INC	$66.25M	-59.10%	-50.70%	-67.11%	-93.10%	0.19	9.34	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$233.52M	-37.60%	-28.90%	-38.29%	-37.90%	0.32	5.43	100.00%	-349.20%	-347.02%
ATXS	ASTRIA THERAPEUTICS INC	$415.93M	-38.60%	-36.10%	-44.31%	-47.90%	0.08	14.89	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$27.36M	-265.40%	-196.40%	-328.17%	937.00%	0.39	3.56	N/A	N/A	N/A
IBO	IMPACT BIOMEDICAL INC	$8.29M	-528.70%	-145.10%	907.95%	-2,020.30%	-2.56	0.06	-57.10%	-549,628.60%	-533,357.14%
CBUS	CIBUS INC	$74.31M	-321.40%	-78.70%	-74.47%	-90.60%	3.77	1.78	100.00%	-5,681.60%	-4,975.71%
TIL	INSTIL BIO INC	$174.03M	-54.30%	-33.70%	-35.38%	-24.40%	0.75	14.97	N/A	N/A	N/A
SVRA	SAVARA INC	$623.94M	-69.10%	-54.80%	-73.49%	-55.80%	0.36	11.08	N/A	N/A	N/A
ORIC	ORIC PHARMACEUTICALS INC	$1.04B	-51.80%	-47.10%	-41.74%	-64.20%	0.07	16.13	N/A	N/A	N/A
FDMT	4D MOLECULAR THERAPEUTICS INC	$317.58M	-40.10%	-36.40%	-44.68%	-49.60%	0.13	8.75	100.00%	-594,375.80%	-594,375.76%
KYTX	KYVERNA THERAPEUTICS INC	$169.09M	-64.90%	-56.10%	-84.94%	-89.40%	0.23	5.39	N/A	N/A	N/A
KRRO	KORRO BIO INC	$294.40M	-61.50%	-42.90%	-55.90%	-48.60%	0.57	5.98	100.00%	-1,454.50%	-1,452.95%
INMB	INMUNE BIO INC	$52.37M	-171.70%	-132.30%	-190.76%	993.00%	0.31	4.20	100.00%	-111,016.00%	-111,016.00%
CLNN	CLENE INC	$62.44M	N/A	-111.70%	-184.73%	-112.90%	-3.59	1.58	80.40%	-10,386.40%	-9,398.60%
GPCR	STRUCTURE THERAPEUTICS INC	$1.16B	-21.30%	-20.30%	-22.96%	-25.90%	0.06	20.48	N/A	N/A	N/A
CHRS	COHERUS BIOSCIENCES INC	$147.24M	N/A	-26.20%	-97.17%	-41.20%	-3.02	1.22	56.60%	-66.30%	-57.09%
IOBT	IO BIOTECH INC	$121.22M	-281.80%	-169.30%	-458.40%	2,120.10%	25.59	1.96	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$8.64B	-41.80%	-35.60%	-36.16%	-43.60%	0.30	11.79	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$102.08M	-44.80%	-37.10%	-42.03%	-302.20%	0.28	18.43	N/A	N/A	N/A
CLDI	CALIDI BIOTHERAPEUTICS INC	$4.24M	N/A	-203.90%	-198.58%	-815.00%	1.12	2.12	N/A	N/A	N/A
NCNA	NUCANA PLC	$0.00	-581.00%	-204.40%	-274.71%	512.50%	1.20	1.58	N/A	N/A	N/A
SPRY	ARS PHARMACEUTICALS INC	$984.31M	-21.80%	-15.90%	-17.82%	-17.50%	0.63	6.17	93.70%	-42.70%	-42.49%
ABSI	ABSCI CORP	$391.75M	-60.20%	-50.90%	-63.13%	-110.20%	0.21	4.39	100.00%	-2,737.90%	-2,724.43%
TELO	TELOMIR PHARMACEUTICALS INC	$42.93M	-4,593.90%	-1,751.00%	-3,355.08%	3,485.50%	0.72	2.38	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$347.44M	-29.80%	-28.10%	-32.37%	-32.90%	0.07	24.51	N/A	N/A	N/A
XFOR	X4 PHARMACEUTICALS INC	$17.31M	29.30%	8.80%	23.07%	23.40%	4.67	3.70	82.40%	46.50%	76.58%
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$3.42B	-42.20%	-36.40%	-40.83%	-78.80%	0.29	16.65	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$5.48M	-475.70%	-184.00%	33.59%	-399.30%	0.42	3.41	N/A	N/A	N/A
TECX	TECTONIC THERAPEUTIC INC	$310.43M	-30.10%	-28.30%	-22.86%	3,469.80%	0.04	25.60	N/A	N/A	N/A
TNGX	TANGO THERAPEUTICS INC	$758.79M	-79.70%	-49.30%	-73.48%	-60.90%	0.76	4.75	100.00%	-599.10%	-598.40%
AVTX	AVALO THERAPEUTICS INC	$133.36M	-48.50%	-35.90%	-41.14%	-3,275.50%	0.21	12.44	242.20%	-10,479.80%	-10,946.03%
LGVN	LONGEVERON INC	$11.49M	-96.70%	-80.30%	-137.68%	-685.10%	0.32	3.43	78.80%	-901.50%	-894.31%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 16 points higher than the biotech industry average of 23.

TBPH passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.34% over the past year, overperforming other biotech stocks by 127 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 78.24% from Theravance Biopharma's current stock price of $14.40.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #2 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 40, which is 17 points higher than the biotech industry average of 23.

RIGL passed 13 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 171.27% over the past year, overperforming other biotech stocks by 221 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $32.00, a downside of -14.21% from Rigel Pharmaceuticals's current stock price of $37.30.

Rigel Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Rigel Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #3 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: D, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 12, which is -11 points lower than the biotech industry average of 23. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 4 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -2.65% over the past year, overperforming other biotech stocks by 47 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $17.13, an upside of 122.4% from Biocryst Pharmaceuticals's current stock price of $7.70.

Biocryst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Biocryst Pharmaceuticals, 37.5% have issued a Strong Buy rating, 50% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Essa Pharma (NASDAQ:EPIX)

Essa Pharma (NASDAQ:EPIX) has an annual dividend yield of 880.74%, which is 753 percentage points higher than the biotech industry average of 127.91%.

Essa Pharma's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 9.11%, which is -119 percentage points lower than the biotech industry average of 127.91%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.48%, which is -125 percentage points lower than the biotech industry average of 127.91%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.46% in the last day, and down -1.01% over the last week. Atyr Pharma was the among the top losers in the biotechnology industry, dropping -83.17% yesterday.

aTyr Pharma shares are trading lower after the company announced topline results from its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.15% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 84.13% in the past year. It has overperformed other stocks in the biotech industry by 134 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has gained 25.19% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

55.4% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 81.39% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.43% of biotech stocks are rated B (Buy), 41.98% are rated C (Hold), 35.44% are rated D (Sell), and 16.03% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -100.7x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.